📰 Pharming Group News
Page 3 - Pharming Group News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharming Group. Real-time updates on events, politics, business and more.
April 19, 2024
Pharming Group (NASDAQ:PHAR – Get Free Report) saw unusually-strong trading volume on Friday . Approximately 4,528 shares were traded during trading, an increase of 72% from the previous session’s volume of 2,625 shares.The stock last traded at $9.35 and had previously closed at $9.33. Analysts Set New Price Targets Separately, HC Wainwright reissued a “buy” […]
April 19, 2024
Pharming Group N.V. Pharming Group N.V. Below you will find information from the register publication of inside information. The information has been...
April 19, 2024
NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. ...
April 19, 2024
Pharming Group (NASDAQ:PHAR – Get Free Report) saw unusually-high trading volume on Friday . Approximately 4,528 shares were traded during trading, an increase of 72% from the previous session’s volume of 2,625 shares.The stock last traded at $9.35 and had previously closed at $9.33. Analyst Ratings Changes Separately, HC Wainwright reissued a “buy” rating and […]
April 18, 2024
18.04.2024 - NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. Pharming Group N.V. launches new convertible bond ...
April 18, 2024
NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. ...
April 8, 2024
This multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency ...
April 8, 2024
This multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency Leiden, the Netherlands, April 8, 2024: Pharming...
April 8, 2024
Pharming Group N.V. Pharming Group N.V. Below you will find information from the register publication of inside information. The information has been...
April 4, 2024
Pharming Group N.V. Pharming Group N.V. Below you will find information from the register publication of inside information. The information has been...